// App-Quantinova.ai

AB0326 : REAL-WORLD EXPERIENCE ON SWITCHING ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN INFLAMMATORY ARTHRITIS – A RETROSPECTIVE STUDY

Researchers

Presenter

  • S. A. Yeoh

Principal Investigators

  • K. Saxby

  • A. Barron

  • S. Moore

  • S. Gani

  • M. Ehrenstein

Medical Centers

  • University College London, Gastroenterology, London, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Medicines Efficiencies Programme, North Central London Sustainability and Transformation Partnership, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • Sex hormone binding globulin

Drug/Treatment

  • Adalimumab

  • ABP 501

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved